Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2012, Article ID 604204, 16 pages
http://dx.doi.org/10.1155/2012/604204
Review Article

Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb

1Research and Development Department, Novagali Pharma SA, 1 rue Pierre Fontaine, 91058 Evry Cedex, France
2The Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, POB 12065, 91120 Jerusalem, Israel

Received 7 September 2011; Accepted 9 November 2011

Academic Editor: Abhijit A. Date

Copyright © 2012 Frederic Lallemand et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [85 citations]

The following is the list of published articles that have cited the current article.

  • N. Zimmermann, and C. Erb, “Therapeutic Strategies in Dry Eye Disease - A Survey of Possible Substitution Therapies and Causal Therapeutic Approaches,” Klinische Monatsblatter Fur Augenheilkunde, vol. 229, no. 12, pp. 1198–1203, 2012. View at Publisher · View at Google Scholar
  • Philippe Daull, Ronald Buggage, Grégory Lambert, Marie-Odile Faure, Janet Serle, Rong-Fang Wang, and Jean-Sébastien Garrigue, “A Comparative Study of a Preservative-Free Latanoprost Cationic Emulsion (Catioprost) and a BAK-Preserved Latanoprost Solution in Animal Models,” Journal of Ocular Pharmacology and Therapeutics, vol. 28, no. 5, pp. 515–523, 2012. View at Publisher · View at Google Scholar
  • Joel G. Souza, Karina Dias, Tatiana Aparecida Pereira, Daniela Spuri Bernardi, and Renata F. V. Lopez, “Topical delivery of ocular therapeutics: carrier systems and physical methods,” Journal of Pharmacy and Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Neha Gadaria-Rathod, Kyu-In Lee, and Penny A Asbell, “Emerging drugs for the treatment of dry eye disease,” Expert Opinion on Emerging Drugs, vol. 18, no. 2, pp. 121–136, 2013. View at Publisher · View at Google Scholar
  • Lin Ying, Kohei Tahara, and Hirofumi Takeuchi, “Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: Effect of emulsion formulations and surface modification,” International Journal of Pharmaceutics, 2013. View at Publisher · View at Google Scholar
  • Guzalia Vagapova, Alsu Ibragimova, Andrey Zakharov, Alexey Dobrynin, Irina Galkina, Lucia Zakharova, and Alexander Konovalov, “Novel biomimetic systems based on polyethylene glycols and amphiphilic phosphonium salt. Self-organization and solubilization of hydrophobic guest,” European Polymer Journal, vol. 49, no. 5, pp. 1031–1039, 2013. View at Publisher · View at Google Scholar
  • Philippe Daull, Frédéric Lallemand, and Jean-Sébastien Garrigue, “Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery,” Journal of Pharmacy and Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Frank Ong, Jane Kuo, Wei-Chi Wu, Ching-Yu Cheng, Wendell-Lamar Blackwell, Brian Taylor, Wayne Grody, Jerome Rotter, Chi-Chun Lai, and Tien Wong, “Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization,” Journal of Personalized Medicine, vol. 3, no. 1, pp. 40–69, 2013. View at Publisher · View at Google Scholar
  • Fahima Dilnawaz, and Sanjeeb Kumar Sahoo, “Nanotechnology-Based Ophthalmic Drug Delivery System,” Focal Controlled Drug Delivery, pp. 225–241, 2013. View at Publisher · View at Google Scholar
  • M. Mazza, M. Alonso-Sande, M.-C. Jones, and M. de la Fuente, “The Potential of Nanoemulsions in Biomedicine,” Fundamentals of Pharmaceutical Nanoscience, pp. 117–158, 2013. View at Publisher · View at Google Scholar
  • Joana F. Fangueiro, Tatiana Andreani, Maria A. Egea, Maria L. Garcia, Selma B. Souto, Amélia M. Silva, and Eliana B. Souto, “Design of cationic lipid nanoparticles for ocular delivery: Development, characterization and cytotoxicity,” International Journal of Pharmaceutics, 2013. View at Publisher · View at Google Scholar
  • Armando Silva-Cunha, Gisele Rodrigues da Silva, Whocely Victor de Castro, and Sílvia Ligório Fialho, “Evaluation of the Pharmacokinetics and Ocular Tolerance of a Microemulsion Containing Tacrolimus,” Journal of Ocular Pharmacology and Therapeutics, pp. 131107061334000, 2013. View at Publisher · View at Google Scholar
  • Jing Qiao, and Xiaoming Yan, “Emerging treatment options for meibomian gland dysfunction.,” Clinical ophthalmology (Auckland, N.Z.), vol. 7, pp. 1797–803, 2013. View at Publisher · View at Google Scholar
  • Yanli Hao, Anbu Mozhi, Xiangdong Xue, Anil Kumar, Fei Chen, Xu Zhang, Yuanyuan Zhao, Paul C. Wang, Xing-Jie Liang, and Xiaoning Zhang, “Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation,” Nanoscale, vol. 5, no. 18, pp. 8307–8325, 2013. View at Publisher · View at Google Scholar
  • M. Amrane, C. Creuzot-Garcher, P.-Y. Robert, D. Ismail, J.-S. Garrigue, P.-J. Pisella, and C. Baudouin, “Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease – A randomised comparative study,” Journal Français d'Ophtalmologie, 2014. View at Publisher · View at Google Scholar
  • Basilio Colligris, Almudena Crooke, Fernando Huete-Toral, and Jesus Pintor, “An update on dry eye disease molecular treatment: advances in drug pipelines,” Expert Opinion on Pharmacotherapy, pp. 1–20, 2014. View at Publisher · View at Google Scholar
  • Aleksander Vladimirovich Vokhmyakov, “The evolution of tear substitutes: from saline solutions to cationic nanoemulsion,” Ophthalmology journal, vol. 7, no. 1, pp. 41–46, 2014. View at Publisher · View at Google Scholar
  • Kati Kinnunen, Anu Kauppinen, Niina Piippo, Arto Koistinen, Elisa Toropainen, and Kai Kaarniranta, “Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures,” Experimental Eye Research, vol. 120, pp. 82–89, 2014. View at Publisher · View at Google Scholar
  • Elias Fattal, and Nicolas Tsapis, “Nanomedicine technology: current achievements and new trends,” Clinical and Translational Imaging, 2014. View at Publisher · View at Google Scholar
  • Frédéric Lallemand, Philippe Daull, and Jean-Sébastien Garrigue, “Development of a Cationic Nanoemulsion Platform (Novasorb®) for Ocular Delivery,” Mucosal Delivery of Biopharmaceuticals, pp. 517–535, 2014. View at Publisher · View at Google Scholar
  • Joana F. Fangueiro, Amélia M. Silva, Maria L. Garcia, and Eliana B. Souto, “Current nanotechnology approaches for the treatment and management of Diabetic Retinopathy,” European Journal of Pharmaceutics and Biopharmaceutics, 2014. View at Publisher · View at Google Scholar
  • Ana Maria Carmona-Ribeiro, and Leticia Dias de Melo Carrasco, “Novel Formulations for Antimicrobial Peptides,” International Journal of Molecular Sciences, vol. 15, no. 10, pp. 18040–18083, 2014. View at Publisher · View at Google Scholar
  • Jiayu Xin, Jingling Tang, Meng Bu, Yanhui Sun, Xinyu Wang, Linhua Wu, and Hongzhuo Liu, “A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy,” Drug Development and Industrial Pharmacy, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Chuanlong Guo, Yan Zhang, Zhao Yang, Mengshuang Li, Fengjie Li, Fenghua Cui, Ting Liu, Weiyun Shi, and Xianggen Wu, “Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation,” Scientific Reports, vol. 5, pp. 12968, 2015. View at Publisher · View at Google Scholar
  • Ralph Pinheiro, Claudia Panfil, Norbert Schrage, and Ralf Michael Dutescu, “Comparison of the lubricant eyedrops Optive®, Vismed Multi®, and Cationorm® on the corneal healing process in an ex vivo model,” European Journal of Ophthalmology, vol. 25, no. 5, pp. 379–384, 2015. View at Publisher · View at Google Scholar
  • Johanna Poecheim, Simon Heuking, Livia Brunner, Christophe Barnier-Quer, Nicolas Collin, and Gerrit Borchard, “Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release,” Nanomaterials, vol. 5, no. 4, pp. 2317–2334, 2015. View at Publisher · View at Google Scholar
  • Agnes Lim, Markus R. Wenk, and Louis Tong, “Lipid-Based Therapy for Ocular Surface Inflammation and Disease,” Trends in Molecular Medicine, 2015. View at Publisher · View at Google Scholar
  • Rosario Pignatello, Claudia Carbone, Carmelo Puglia, Alessia Offerta, Francesco P Bonina, and Giovanni Puglisi, “Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity,” Therapeutic Delivery, vol. 6, no. 11, pp. 1297–1318, 2015. View at Publisher · View at Google Scholar
  • Sushilkumar Patil, Imran Vhora, Jitendra Amrutiya, Rohan Lalani, and Ambikanandan Misra, “Role of Nanotechnology in Delivery of Protein and Peptide Drugs,” Current Pharmaceutical Design, vol. 21, no. 29, pp. 4155–4173, 2015. View at Publisher · View at Google Scholar
  • George Ousler, Douglas K Devries, Paul M Karpecki, and Joseph B Ciolino, “An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye.,” Clinical ophthalmology (Auckland, N.Z.), vol. 9, pp. 235–43, 2015. View at Publisher · View at Google Scholar
  • Haliza Abdul Mutalib, Sharanjeet Kaur, Ahmad Rohi Ghazali, Ng Chinn Hooi, and Nor Hasanah Safie, “A Pilot Study: The Efficacy of Virgin Coconut Oil as Ocular Rewetting Agent on Rabbit Eyes,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Nirav Patel, Happy Nakrani, Mihir Raval, and Navin Sheth, “ Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability ,” Drug Delivery, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Luís F. Neves, Jinghua Duan, Adrienne Voelker, Anil Khanal, Lacey McNally, Jill Steinbach-Rankins, and Brian P. Ceresa, “Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells,” Journal of Microencapsulation, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Li-Qiu Mu, Wei Dai, Chuan-Bang Wang, Xin-Yi Liu, Da-Xiong Xiang, and Ting-Ting Liu, “Preparation, characterization, and evaluation of antitumor effect of Brucea javanica oil cationic nanoemulsions,” International Journal of Nanomedicine, vol. 11, pp. 2515–2529, 2016. View at Publisher · View at Google Scholar
  • Katla Venu Madhav, and Veerabrahma Kishan, “Cationic solid self micro emulsifying drug delivery system (SSMED) of losartan: Formulation development, characterization and in vivo evaluation,” Journal of Drug Delivery Science and Technology, 2016. View at Publisher · View at Google Scholar
  • Katherine A. Lyseng-Williamson, “Cationorm® (cationic emulsion eye drops) in dry eye disease: a guide to its use,” Drugs & Therapy Perspectives, 2016. View at Publisher · View at Google Scholar
  • Rawia M. Khalil, Ghada A. Abdelbary, Mona Basha, Ghada E. A. Awad, and Hadeer A. El-Hashemy, “Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl,” Journal of Liposome Research, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Stephanie H. Choi, and Robert A. Lionberger, “Clinical, Pharmacokinetic, and In Vitro Studies to Support Bioequivalence of Ophthalmic Drug Products,” The AAPS Journal, 2016. View at Publisher · View at Google Scholar
  • Neelesh K. Mehra, Defu Cai, Lih Kuo, Travis Hein, and Srinath Palakurthi, “Safety and toxicity of nanomaterials for ocular drug delivery applications,” Nanotoxicology, pp. 1–22, 2016. View at Publisher · View at Google Scholar
  • Purnima Verma, and Munish Ahuja, “Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide,” Drug Delivery, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Sohail Akhter, Mohammed Anwar, Mohammad Ahsan Siddiqui, Iqbal Ahmad, Javed Ahmad, Mohammad Zaki Ahmad, Aseem Bhatnagar, and Farhan Jalees Ahmad, “Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: Formulation development, in-vitro and in-vivo studies,” Colloids and Surfaces B: Biointerfaces, vol. 148, pp. 19–29, 2016. View at Publisher · View at Google Scholar
  • R. Michael Dutescu, Claudia Panfil, and Norbert Schrage, “Comparison of the effects of various lubricant eye drops on the in vitro rabbit corneal healing and toxicity,” Experimental and Toxicologic Pathology, 2016. View at Publisher · View at Google Scholar
  • Lunawati Bennett, “Drug Delivery to Specific Compartments of the Eye,” Ocular Drug Delivery: Advances, Challenges and Applications, pp. 37–52, 2016. View at Publisher · View at Google Scholar
  • Lunawati Bennett, “Topical Versus Systemic Ocular Drug Delivery,” Ocular Drug Delivery: Advances, Challenges and Applications, pp. 53–74, 2016. View at Publisher · View at Google Scholar
  • Daull Philippe, Feraille Laurence, Barabino Stefano, Cimbolini Nicolas, Antonelli Sophie, Mauro Virgine, and Garrigue Jean-Sébastien, “Efficacy of a new topical cationic emulsion of cyclosporine A on dry eye clinical signs in an experimental mouse model of dry eye,” Experimental Eye Research, 2016. View at Publisher · View at Google Scholar
  • Philippe Daull, Laurence Feraille, Pierre-Paul Elena, and Jean-Sébastien Garrigue, “Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping,” Journal of Ocular Pharmacology and Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Ankur Gupta, H. Burak Eral, T. Alan Hatton, and Patrick S. Doyle, “Nanoemulsions: formation, properties and applications,” Soft Matter, vol. 12, no. 11, pp. 2826–2841, 2016. View at Publisher · View at Google Scholar
  • Anna M Ambroziak, Jerzy Szaflik, Jacek P Szaflik, Maciej Ambroziak, Jan Witkiewicz, and Piotr Skopiński, “Immunomodulation on the ocular surface: a review.,” Central-European journal of immunology, vol. 41, no. 2, pp. 195–208, 2016. View at Publisher · View at Google Scholar
  • Christophe Baudouin, Francisco C. Figueiredo, Dahlia Ismail, Mourad Amrane, Jean-Sébastien Garrigue, Andrea Leonardi, Elisabeth M. Messmer, and Stefano Bonini, “A randomized study of the efficacy and safety of 0.1% cyclosporine a cationic emulsion in treatment of moderate to severe dry eye,” European Journal of Ophthalmology, vol. 27, no. 5, pp. 520–530, 2017. View at Publisher · View at Google Scholar
  • George W. Ousler, David Rimmer, Lisa M. Smith, and Mark B. Abelson, “Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review,” Ophthalmology and Therapy, 2017. View at Publisher · View at Google Scholar
  • Jean-Sébastien Garrigue, Mourad Amrane, Marie-Odile Faure, Juha M. Holopainen, and Louis Tong, “Relevance of Lipid-Based Products in the Management of Dry Eye Disease,” Journal of Ocular Pharmacology and Therapeutics, 2017. View at Publisher · View at Google Scholar
  • Georgi Georgiev, Norihiko Yokoi, Yana Nencheva, Nikola Peev, and Philippe Daull, “Surface Chemistry Interactions of Cationorm with Films by Human Meibum and Tear Film Compounds,” International Journal of Molecular Sciences, vol. 18, no. 7, pp. 1558, 2017. View at Publisher · View at Google Scholar
  • Grazia M.L. Consoli, Ivana Di Bari, Anna Rita Blanco, Antonia Nostro, Manuela D'Arrigo, Venerando Pistarà, and Salvatore Sortino, “Design, Synthesis and Antibacterial Activity of a Multivalent Polycationic Calix[4]arene‒NO Photodonor Conjugate,” ACS Medicinal Chemistry Letters, 2017. View at Publisher · View at Google Scholar
  • Reza Dana, Sophie X. Deng, Pham N. Dong, Gerd Geerling, Richard Yudi Hida, Yang Liu, Kyoung Yul Seo, Joseph Tauber, Tais H. Wakamatsu, Jianjiang Xu, James S. Wolffsohn, Jennifer P. Craig, Lyndon Jones, Laura E. Downie, Donald Korb, and Jose M. Benitez-del-Castillo, “TFOS DEWS II Management and Therapy Report,” The Ocular Surface, vol. 15, no. 3, pp. 575–628, 2017. View at Publisher · View at Google Scholar
  • Lida Lalu, Vishakha Tambe, Deepak Pradhan, Kritika Nayak, Suchandra Bagchi, Rahul Maheshwari, Kiran Kalia, and Rakesh Kumar Tekade, “Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions,” Journal of Controlled Release, 2017. View at Publisher · View at Google Scholar
  • Prina Mehta, Rita Haj-Ahmad, Ali Al-Kinani, Muhammad Sohail Arshad, Ming-Wei Chang, Raid G Alany, and Zeeshan Ahmad, “Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices,” Therapeutic Delivery, vol. 8, no. 7, pp. 521–541, 2017. View at Publisher · View at Google Scholar
  • Giuseppe Granata, Irene Paterniti, Corrada Geraci, Francesca Cunsolo, Emanuela Esposito, Marika Cordaro, Anna Rita Blanco, Salvatore Cuzzocrea, and Grazia M. L. Consoli, “Potential Eye Drop Based on a Calix[4]arene Nanoassembly for Curcumin Delivery: Enhanced Drug Solubility, Stability, and Anti-Inflammatory Effect,” Molecular Pharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Frédéric Lallemand, Mathieu Schmitt, Jean-Louis Bourges, Robert Gurny, Simon Benita, and Jean-Sébastien Garrigue, “Cyclosporine A delivery to the eye: a comprehensive review of academic and industrial efforts,” European Journal of Pharmaceutics and Biopharmaceutics, 2017. View at Publisher · View at Google Scholar
  • Palpandi Pandi, Anjali Jain, Saka Raju, and Wahid Khan, “ Therapeutic approaches for the delivery of TNF-α siRNA ,” Therapeutic Delivery, vol. 8, no. 5, pp. 343–355, 2017. View at Publisher · View at Google Scholar
  • Andrea Leonardi, Bruno Flamion, and Christophe Baudouin, “Keratitis in Dry Eye Disease and Topical Ciclosporin A,” Ocular Immunology and Inflammation, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Antónia Gonçalves, Nooshin Nikmaram, Shahin Roohinejad, Berta N. Estevinho, Fernando Rocha, Ralf Greiner, and David Julian McClements, “Production, properties, and applications of solid self-emulsifying delivery systems (S-SEDS) in the food and pharmaceutical industries,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2017. View at Publisher · View at Google Scholar
  • Kousalya Selvaraj, Kuppusamy Gowthamarajan, Veera Venkata Satyanarayana Reddy Karri, Uday K. Barauah, Vanka Ravisankar, and Gifty M. Jojo, “Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy,” Journal of Drug Targeting, pp. 1–20, 2017. View at Publisher · View at Google Scholar
  • Yasmina Iffet Eroglu, “A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutes.,” Journal of market access & health policy, vol. 5, no. 1, pp. 1336043, 2017. View at Publisher · View at Google Scholar
  • Rashmin B. Patel, Mrunali R. Patel, Shivam D. Thakore, and Bharat G. Patel, “Nanoemulsion as a Valuable Nanostructure Platform for Pharmaceutical Drug Delivery,” Nano- and Microscale Drug Delivery Systems, pp. 321–341, 2017. View at Publisher · View at Google Scholar
  • Hung Thanh Lam, Bao Le-Vinh, Thi Nhu Quynh Phan, and Andreas Bernkop-Schnürch, “Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity?,” Journal of Pharmacy and Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Megumi Nishitani Yukuyama, Pedro Leonidas Oseliero Filho, Edna Tomiko Myiake Kato, Raimar Lobënberg, Cristiano Luis Pinto de Oliveira, Gabriel Lima Barros de Araujo, and Nadia Araci Bou-Chacra, “High internal vegetable oil nanoemulsion: D-phase emulsification as a unique low energy process,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2018. View at Publisher · View at Google Scholar
  • Konstadinos G. Boboridis, and Anastasios G.P. Konstas, “Evaluating the novel application of cyclosporine 0.1% in ocular surface disease,” Expert Opinion on Pharmacotherapy, pp. 1–13, 2018. View at Publisher · View at Google Scholar
  • Pierre-Yves Robert, Béatrice Cochener, Mourad Amrane, Dahlia Ismail, Jean-Sébastien Garrigue, Pierre-Jean Pisella, and Christophe Baudouin, “Efficacy and Safety of a Cationic Emulsion in the Treatment of Moderate to Severe Dry Eye Disease: A Randomized Controlled Study,” European Journal of Ophthalmology, vol. 26, no. 6, pp. 546–555, 2018. View at Publisher · View at Google Scholar
  • Andrea Leonardi, Elisabeth M Messmer, Marc Labetoulle, Mourad Amrane, Jean-Sébastien Garrigue, Dahlia Ismail, Maite Sainz-de-la-Maza, Francisco C Figueiredo, and Christophe Baudouin, “Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies,” British Journal of Ophthalmology, vol. 103, no. 1, pp. 125–131, 2018. View at Publisher · View at Google Scholar
  • O. A. Kiseleva, A. M. Bessmertny, and L. V. Yakubova, “New technologies of hypotensive drug delivery in glaucoma treatment,” Russian Ophthalmological Journal, vol. 11, no. 4, pp. 103–107, 2018. View at Publisher · View at Google Scholar
  • Ziyi Wen, Natsuko Muratomi, Wei Huang, Liqun Huang, Jinfeng Ren, Jennifer Yang, Yogeeta Persaud, Justin Loloi, Naveen Mallangada, Preston Kung, Robert Honkanen, and Basil Rigas, “The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: Enhanced and targeted tissue drug delivery,” International Journal of Pharmaceutics, 2018. View at Publisher · View at Google Scholar
  • Philippe Daull, Elisabeth Raymond, Laurence Feraille, and Jean-Sébastien Garrigue, “Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas,” Journal of Ocular Pharmacology and Therapeutics, 2018. View at Publisher · View at Google Scholar
  • Doaa Hassan, Rehab Abdelmonem, and Menna Abdellatif, “Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study,” Pharmaceutics, vol. 10, no. 4, pp. 197, 2018. View at Publisher · View at Google Scholar
  • Marion Dubald, Sandrine Bourgeois, Véronique Andrieu, and Hatem Fessi, “Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review,” Pharmaceutics, vol. 10, no. 1, pp. 10, 2018. View at Publisher · View at Google Scholar
  • Maria Aurora Grimaudo, Silvia Pescina, Cristina Padula, Patrizia Santi, Angel Concheiro, Carmen Alvarez-Lorenzo, and Sara Nicoli, “Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery,” Molecular Pharmaceutics, 2018. View at Publisher · View at Google Scholar
  • Kamla Pathak, Satyanarayan Pattnaik, and Kalpana Swain, “Application of Nanoemulsions in Drug Delivery,” Nanoemulsions, pp. 415–433, 2018. View at Publisher · View at Google Scholar
  • Priyanka Agarwal, Di Huang, Sachin S. Thakur, and Ilva D. Rupenthal, “Nanotechnology for ocular drug delivery,” Design of Nanostructures for Versatile Therapeutic Applications, pp. 137–188, 2018. View at Publisher · View at Google Scholar
  • I. A. Bubnova, G. B. Egorova, T. S. Mitichkina, V. V. Averich, and E. I. Fettser, “Secondary dry eye syndrome after keratorefractive surgeries and approaches to its treatment and prevention,” Vestnik oftal'mologii, vol. 134, no. 5, pp. 294, 2018. View at Publisher · View at Google Scholar
  • Maria Christina Camasmie Peters, Edson dos Santos Neto, Lis Marie Monteiro, Megumi Nishitani Yukuyama, Marcella Gabrielle Mendes Machado, Isabela Fernandes de Oliveira, Maria Helena Ambrosio Zanin, Raimar Löbenberg, and Nádia Bou-Chacra, “Advances in ophthalmic preparation: the role of drug nanocrystals and lipid-based nanosystems,” Journal of Drug Targeting, pp. 1–12, 2019. View at Publisher · View at Google Scholar
  • Eliana B. Souto, João Dias-Ferreira, Ana López-Machado, Miren Ettcheto, Amanda Cano, Antonio Camins Espuny, Marta Espina, Maria Luisa Garcia, and Elena Sánchez-López, “Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents,” Pharmaceutics, vol. 11, no. 9, pp. 460, 2019. View at Publisher · View at Google Scholar
  • Yongjie Lu, Yau Kei Chan, Long Hei Lau, David Wong, Jasper Ka Wai Wong, Kendrick Co Shih, Shiu Ming Lai, and Ho Cheung Shum, “Amphiphilic additives in silicone oil tamponade and emulsification: an eye‐on‐a‐chip study,” Acta Ophthalmologica, 2019. View at Publisher · View at Google Scholar
  • Cesar Torres-Luna, Naiping Hu, Abdollah Koolivand, Xin Fan, Yuli Zhu, Roman Domszy, Jeff Yang, Arthur Yang, and Nam Sun Wang, “Effect of a Cationic Surfactant on Microemulsion Globules and Drug Release from Hydrogel Contact Lenses,” Pharmaceutics, vol. 11, no. 6, pp. 262, 2019. View at Publisher · View at Google Scholar
  • L. I. Uchakova, S. V. Balalin, and V. L. Zagrebin, “Stimulation of Basal Secretion in the Treatment of Dry Eye Syndrome,” Ophthalmology in Russia, vol. 16, no. 1, pp. 70–75, 2019. View at Publisher · View at Google Scholar
  • Jorge Jimenez, Meera Sakthivel, Kanwal K. Nischal, and Morgan V. Fedorchak, “Drug delivery systems and novel formulations to improve treatment of rare corneal disease,” Drug Discovery Today, 2019. View at Publisher · View at Google Scholar
  • Bruna Galdorfini Chiari-Andréo, Maria Gabriela José de Almeida-Cincotto, João Augusto Oshiro, Cibele Yumi Yamada Taniguchi, Leila Aparecida Chiavacci, and Vera Lucia Borges Isaac, “Nanoparticles for cosmetic use and its application,” Nanoparticles in Pharmacotherapy, pp. 113–146, 2019. View at Publisher · View at Google Scholar